IGF2 is a potential factor in RAI-refractory differentiated thyroid cancer.
Crezee T, Tesselaar MH, Jaeger M, Rabold K, Corver WE, Morreau H, Van Engen-Van Grunsven ACH, Smit JWA, Netea-Maier RT, Plantinga TS.
Crezee T, et al.
Oncol Lett. 2021 Aug;22(2):590. doi: 10.3892/ol.2021.12851. Epub 2021 Jun 6.
Oncol Lett. 2021.
PMID: 34149901
Free PMC article.